Drug Profile
Sodium fluoride - Mission Pharmacal
Alternative Names: Fluoride - Mission Pharmacal; Neosten; Slow Fluoride; SR-NaFLatest Information Update: 21 Nov 2021
Price :
$50
*
At a glance
- Originator Mission Pharmacal; University of Texas Southwestern Medical Center
- Class Fluorides; Osteoporosis therapies
- Mechanism of Action Osteogenesis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Postmenopausal osteoporosis
Most Recent Events
- 02 May 2005 No development reported - Preregistration for Postmenopausal osteoporosis in USA (PO)
- 22 May 2000 Registered for Postmenopausal osteoporosis in Germany (PO)
- 10 Feb 1999 Preregistration for Postmenopausal osteoporosis in USA (PO)